Probiotic Medilac-S® for the induction of clinical remission in a Chinese population with ulcerative colitis: A systematic review and meta-analysis

Figure 10 Funnel plots showing the relationship between the relative risk and its standard error for (A) 7 studies used in a random effects meta-analysis evaluating the efficacy of Medilac-S^® in combination with conventional drug therapy on change in mean endoscopic score (B) 8 studies used in a fixed effects meta-analysis evaluating the efficacy of Medilac-S^® in combination with conventional drug therapy on change in mean endoscopic score and (C) 30 studies used in a fixed effects meta-analysis evaluating the efficacy of Medilac-S^® in combination with conventional drug therapy on change in the number of reported adverse events.